Cargando…
PTH(1-34) improves bone healing by promoting angiogenesis and facilitating MSCs migration and differentiation in a stabilized fracture mouse model
OBJECTIVE: PTH(1-34) (parathyroid hormone 1–34) is the only clinical drug to promote osteogenesis. MSCs (mesenchymal stem cells) have multidirectional differentiation potential and are closely related to fracture healing. This study was to explore the effects of PTH(1-34) on proliferation and differ...
Autores principales: | Jiang, Xin, Xu, Cuidi, Shi, Hongli, Cheng, Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903750/ https://www.ncbi.nlm.nih.gov/pubmed/31821371 http://dx.doi.org/10.1371/journal.pone.0226163 |
Ejemplares similares
-
Endogenous PTH Deficiency Impairs Fracture Healing and Impedes the Fracture-Healing Efficacy of Exogenous PTH(1-34)
por: Ren, Yongxin, et al.
Publicado: (2011) -
Continuous infusion of PTH(1–34) delayed fracture healing in mice
por: Yukata, Kiminori, et al.
Publicado: (2018) -
Cyasterone accelerates fracture healing by promoting MSCs migration and osteogenesis
por: Zhu, Junlang, et al.
Publicado: (2021) -
P311 Facilitates the Angiogenesis and Wound Healing Function of MSCs by Increasing VEGF Production
por: Liu, Zhihui, et al.
Publicado: (2022) -
Therapeutic Potentials of Dimeric (Cys25)PTH(1–34) Peptide for Osteoporosis and Fracture Healing of the Bones- Buy One, Get One Free
por: Park, Doori, et al.
Publicado: (2021)